BridgeBio Pharma (NASDAQ:BBIO) was upgraded by analysts at Oppenheimer Holdings, Inc. from a "market perform" rating to an "outperform" rating. They now have a $60.00 price target on the stock. This represents a 34.0% upside from the current price of $44.79. |
Bloom Energy (NYSE:BE) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $33.00 price target on the stock, up previously from $18.00. This represents a 24.6% upside from the current price of $26.48. |
Brown-Forman (NYSE:BF.B) was upgraded by analysts at Rothschild & Co Redburn from a "sell" rating to a "neutral" rating. They now have a $30.00 price target on the stock. This represents a 5.3% upside from the current price of $28.48. |
Caterpillar (NYSE:CAT) was upgraded by analysts at Melius from a "hold" rating to a "buy" rating. They now have a $500.00 price target on the stock. This represents a 24.3% upside from the current price of $402.19. |
Citizens Financial Group (NYSE:CFG) was upgraded by analysts at Keefe, Bruyette & Woods from a "market perform" rating to an "outperform" rating. They now have a $57.00 price target on the stock. This represents a 19.1% upside from the current price of $47.85. |
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $200.00 price target on the stock, up previously from $150.00. This represents a 24.5% upside from the current price of $160.60. |
Doximity (NASDAQ:DOCS) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $70.00 price target on the stock, up previously from $50.00. This represents a 9.1% upside from the current price of $64.13. |
FOX (NASDAQ:FOXA) was upgraded by analysts at Wolfe Research from an "underperform" rating to a "peer perform" rating.The current price is $55.10. |
Haemonetics (NYSE:HAE) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $90.00 price target on the stock. This represents a 13.3% upside from the current price of $79.42. |
Hologic (NASDAQ:HOLX) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $80.00 price target on the stock, up previously from $60.00. This represents a 22.3% upside from the current price of $65.42. |
JPMorgan Chase & Co. (NYSE:JPM) was upgraded by analysts at Keefe, Bruyette & Woods from a "market perform" rating to an "outperform" rating. They now have a $327.00 price target on the stock. This represents a 15.0% upside from the current price of $284.32. |
Morgan Stanley (NYSE:MS) was upgraded by analysts at Keefe, Bruyette & Woods from a "market perform" rating to an "outperform" rating. They now have a $160.00 price target on the stock, up previously from $127.00. This represents a 12.2% upside from the current price of $142.66. |
Microsoft (NASDAQ:MSFT) was upgraded by analysts at Oppenheimer Holdings, Inc. from a "market perform" rating to an "outperform" rating. They now have a $600.00 price target on the stock. This represents a 19.0% upside from the current price of $504.18. |
The PNC Financial Services Group (NYSE:PNC) was upgraded by analysts at Keefe, Bruyette & Woods from an "underperform" rating to a "market perform" rating. They now have a $212.00 price target on the stock, up previously from $185.00. This represents a 5.8% upside from the current price of $200.34. |
Sunrun (NASDAQ:RUN) was upgraded by analysts at Jefferies Financial Group Inc. from an "underperform" rating to a "hold" rating. They now have a $11.00 price target on the stock, up previously from $5.00. This represents a 10.7% upside from the current price of $9.94. |
J. M. Smucker (NYSE:SJM) was upgraded by analysts at BNP Paribas Exane from an "underperform" rating to an "outperform" rating. They now have a $120.00 price target on the stock. This represents a 15.0% upside from the current price of $104.38. |
The Hanover Insurance Group (NYSE:THG) was upgraded by analysts at Keefe, Bruyette & Woods from a "market perform" rating to an "outperform" rating. They now have a $188.00 price target on the stock. This represents a 14.4% upside from the current price of $164.31. |
Warner Music Group (NASDAQ:WMG) was upgraded by analysts at Bank of America Corporation from an "underperform" rating to a "neutral" rating. They now have a $33.00 price target on the stock, up previously from $28.00. This represents a 9.0% upside from the current price of $30.27. |